| __timestamp | Opthea Limited | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2652041 | 24518692 |
| Thursday, January 1, 2015 | 2361587 | 19886580 |
| Friday, January 1, 2016 | 4472869 | 12631689 |
| Sunday, January 1, 2017 | 5030957 | 21977998 |
| Monday, January 1, 2018 | 4988941 | 20759000 |
| Tuesday, January 1, 2019 | 5196412 | 20838000 |
| Wednesday, January 1, 2020 | 6652774 | 121812000 |
| Friday, January 1, 2021 | 18418247 | 152137000 |
| Saturday, January 1, 2022 | 24827066 | 83231000 |
| Sunday, January 1, 2023 | 41896408 | 122706000 |
| Monday, January 1, 2024 | 15488619 |
Unleashing the power of data
In the dynamic world of biotechnology, understanding financial trends is crucial for investors and stakeholders. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Opthea Limited and TG Therapeutics, Inc. from 2014 to 2023. Over this period, TG Therapeutics, Inc. consistently outpaced Opthea Limited in SG&A spending, peaking in 2021 with expenses nearly 6 times higher than Opthea's. Notably, TG Therapeutics saw a dramatic increase in 2020, with expenses surging by over 500% compared to 2019. Meanwhile, Opthea's SG&A expenses showed a steady upward trend, culminating in a significant spike in 2023, marking a 170% increase from the previous year. These trends highlight the aggressive expansion strategies of both companies, with TG Therapeutics leading the charge. Missing data for 2024 suggests a need for cautious interpretation of future projections.
Selling, General, and Administrative Costs: Johnson & Johnson vs Opthea Limited
Breaking Down SG&A Expenses: Amgen Inc. vs Opthea Limited
Operational Costs Compared: SG&A Analysis of Bristol-Myers Squibb Company and Opthea Limited
Operational Costs Compared: SG&A Analysis of Neurocrine Biosciences, Inc. and TG Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Insmed Incorporated and TG Therapeutics, Inc.
Comparing SG&A Expenses: Ascendis Pharma A/S vs TG Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs Opthea Limited
Halozyme Therapeutics, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Pharming Group N.V. vs TG Therapeutics, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Opthea Limited and Amicus Therapeutics, Inc.
Opthea Limited or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
TG Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends